31
Monoclonal Antibody Treatment for Non-Hodgkin’s Lymphoma (Low-Grade)
Condition(s):Non-Hodgkin’s LymphomaLast Updated:December 28, 2007Completed
Epratuzumab: 42 Clinical Trials, Page 4 of 5
Hide Studies Not Open or Pending
32
Clinical and Pathologic Studies in Non-Hodgkin’s Lymphoma Patients Receiving Antibody Treatment
Condition(s):Lymphoma, Non-Hodgkin; Lymphomas: Non-Hodgkin; Lymphomas: Non-Hodgkin Cutaneous Lymphoma; Lymphomas: Non-Hodgkin Diffuse Large B-Cell; Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell; Lymphomas: Non-Hodgkin Mantle Cell; Lymphomas: Non-Hodgkin Marginal Zone; Lymphomas: Non-Hodgkin Peripheral T-Cell; Lymphomas: Non-Hodgkin Waldenstr MacroglobulinemiaLast Updated:June 2, 2011Completed
33
Treatment of Non-Hodgkin’s Lymphoma With 90Y-hLL2 IgG
Condition(s):Non-Hodgkin’s Lymphoma; Lymphoma, B-CellLast Updated:August 19, 2021Completed
34
Study of 90Y-hLL2 to Treat Non-Hodgkin’s Lymphoma
Condition(s):Non-Hodgkins LymphomaLast Updated:August 16, 2021Terminated
35
Safety Study of NHL With 90Y-hLL2 IgG
Condition(s):NHL; B-cell NHL; Non-Hodgkins LymphomaLast Updated:August 16, 2021Completed
36
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
Condition(s):Leukemia; LymphomaLast Updated:June 22, 2011Completed
37
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin’s Lymphoma
Condition(s):LymphomaLast Updated:August 16, 2021Unknown status
38
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin’s Lymphoma
Condition(s):LymphomaLast Updated:August 16, 2021Unknown status
39
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Condition(s):Non-Hodgkin’s Lymphoma; Chronic Lymphocytic LeukemiaLast Updated:May 29, 2018Completed
40
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom’s Macroglobulinemia
Condition(s):Leukemia; LymphomaLast Updated:June 22, 2011Completed